Tag: NASDAQ:BIDU
-
Chubb Stock Soars 9% with Berkshire Acquisition, AST SpaceMobile jumps 37% on AT&T deal, and More News
Berkshire Hathaway (NYSE:BRK.A), Chubb (NYSE:CB) – Chubb’s stock increased by approximately 9.3% after Berkshire Hathaway disclosed its acquisition of nearly 26 million shares of the property and casualty insurer, representing a $6.7 billion investment. As a result, Chubb became Berkshire’s ninth-largest holding by the end of March, as recorded in a new regulatory document. Netflix…
-
US Stock Futures Rise Amid Softer Inflation, Oil Prices Dip
U.S. index futures show a slight uptick in pre-market trading on Thursday, buoyed by softer-than-expected inflation. This optimistic scenario has helped the S&P 500 surpass the 5,300 point mark for the first time, signaling potential relief in inflationary pressures and rejuvenating investor spirits. At 6:37 AM, the Dow Jones (DOWI:DJI) futures rose by 16 points,…
-
Novavax Surges 57% Post $1.4 Billion Sanofi Deal; Apple Boosts Data Centers with AI and Internal Chips, and More News
Novavax (NASDAQ:NVAX), Sanofi (NASDAQ:SNY) – Novavax closed a $1.4 billion deal with Sanofi to commercialize its Covid-19 vaccine and develop a new combined vaccine against coronavirus and influenza, boosting NVAX shares by 56.70% in pre-market. The deal led Novavax to suspend its continuity warning, reversing its previous financial decline. Apple (NASDAQ:AAPL) – Apple plans to…
-
Philips Stocks Soar 47% Following US Deal, Tesla Bolsters Presence in China, and More News
Philips (NYSE:PHG) – Philips’ stock soared 47.1% in pre-market trading after announcing a $1.1 billion deal to resolve U.S. claims related to a respiratory device recall. Analysts consider the settlement far below expectations, eliminating uncertainties that impacted the market value. Tesla (NASDAQ:TSLA), Baidu (NASDAQ:BIDU) – Tesla has overcome regulatory hurdles in China to launch its…
-
Philips Shares Drop 6% as US Sales Halted Following Agreement on Faulty Sleep Apnea Devices, and latest news
Royal Philips NV (NYSE:PHG) – Royal Philips NV has suspended sales of sleep apnea devices and ventilators in the US after reaching an agreement with the US Food and Drug Administration due to quality issues. Philips has set aside 363 million euros in the fourth quarter to cover the costs of the agreement. The company…